Renaissance Technologies - PLUS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of PLUS THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$77
+208.0%
264,310
+237.3%
0.00%
Q4 2022$25
-99.9%
78,370
+10.5%
0.00%
Q3 2022$32,000
-41.8%
70,900
-29.9%
0.00%
Q2 2022$55,000
-17.9%
101,093
+50.1%
0.00%
Q1 2022$67,000
-69.1%
67,358
-67.4%
0.00%
Q4 2021$217,000
+382.2%
206,500
+1072.8%
0.00%
Q2 2021$45,000
-79.0%
17,607
-83.4%
0.00%
Q4 2020$214,000
+137.8%
106,100
+202.7%
0.00%
Q3 2020$90,000
-49.4%
35,049
-58.2%
0.00%
Q2 2020$178,000
+17.1%
83,949
+3.6%
0.00%
Q1 2020$152,000
-26.2%
81,049
-5.4%
0.00%
Q4 2019$206,000
+73.1%
85,634
+146.6%
0.00%
Q3 2019$119,00034,7310.00%
Other shareholders
PLUS THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Parkman Healthcare Partners LLC 583,467$184,9590.05%
GREAT VALLEY ADVISOR GROUP, INC. 33,600$10,6510.00%
Schonfeld Strategic Advisors LLC 190,400$60,3570.00%
Virtu Financial LLC 13,647$40.00%
Creative Planning 33,539$10,6320.00%
ROYAL BANK OF CANADA 1$00.00%
VANGUARD GROUP INC 1,092,953$346,4660.00%
Warberg Asset Management LLC 10,000$3,1700.00%
UBS Group AG 19,003$6,0810.00%
TWO SIGMA INVESTMENTS, LP 10,600$3,3600.00%
View complete list of PLUS THERAPEUTICS INC shareholders